NET PROFIT (x1000 SEK)
EMPLOYEES
TILT Biotherapeutics Oy
Closing information (x1000 SEK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Financial expenses |
1,387
|
18
|
0 |
| Earnings before taxes |
-13,317
|
-3,508
|
-837 |
| Total assets |
39,310
|
16,754
|
3,016 |
| Current assets |
38,966
|
16,543
|
2,217 |
| Current liabilities |
1,148
|
639
|
247 |
| Equity capital |
26,472
|
11,501
|
1,351 |
| - share capital |
29
|
27
|
29 |
| Employees (average) |
7
|
3
|
2 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
67.3%
|
68.6%
|
44.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-30.3%
|
-20.8%
|
-27.8% |
| Current ratio |
3394.3%
|
2588.9%
|
897.6% |
| Return on equity (ROE) |
-50.3%
|
-30.5%
|
-62.0% |
| Change turnover | |||
| Change turnover % | |||
| Chg. No. of employees |
4
|
1
|
0 |
| Chg. No. of employees % |
133%
|
50%
|
0% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.